• 1
    Blasko JC, Ragde H, Schumacher D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocurie/Hypertherm Oncol. 1987; 3: 131139.
  • 2
    Cooperberg M, Lubeck D, Meng M, Mehta S, Carroll P. The changing face of low-risk prostate cancer: trends in clinical prsentation and primary management. J Clin Oncol. 2004; 22: 21412149.
  • 3
    Hakenberg O, Wirth M, Hermann T, et al. Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy. Urol Int. 2002; 70: 1520.
  • 4
    Pisansky T, Blute M, Hillman D, et al. The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinoma. Cancer. 2002; 95: 513519.
  • 5
    Khan MA, Partin AW. Partin tables: past and present. BJU Int. 2003; 92: 711.
  • 6
    Febles C, Valicenti R. Combining external beam radiotherapy with prostate brachytherapy: issues and rationale. Urology. 2004; 64: 855861.
  • 7
    D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969974.
  • 8
    Brachman DG, Thomas T, Hilbe J, Beyer DC. Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice. Int J Radiat Oncol Biol Phys. 2000; 48: 111117.
  • 9
    Blasko JC, Grimm PD, Sylvester JE, Badiozamani KR, Hoak D, Cavanagh W. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 2000; 46: 839850.
  • 10
    Merrick G, Butler W, Wallner K, Galbreath R, Adamovich E. Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA <20 ng/ml. Am J Clin Oncol. 2004; 27: 611615.
  • 11
    Merrick G, Butler W, Lief JH, Galbreath RW, Adamovich E. Biochemical outcome for hormone-naive intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation. Brachytherapy. 2002; 1: 95101.
  • 12
    Stock RG, Cahlon O, Cesaretti J, Kollmeier M, Stone NN. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2004; 59: 13521359.
  • 13
    Dattoli MJ, Wallner KE, True L, Cash JC, Sorace RA. Prognostic Role of serum prostatic acid phosphatase for Pd-103 based radiation for prostatic carcinoma. Int J Radiat Oncol Biol Phys. 1999; 45: 853856.
  • 14
    Roy AV, Brower ME, Hayden JE. Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin Chem. 1998; 17: 10931102.
  • 15
    Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC. Comparison of biochemical failure definitions for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006; 65: 14871493.
  • 16
    Denham JW, Steigler A, Lamb D, et al. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet. 2005; 6: 841850.
  • 17
    D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004; 293: 821827.
  • 18
    Davis BJ, Pisansky TM, Wilson TM, et al. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Cancer. 1999; 85: 26302637.
  • 19
    Butzbach D, Waterman FM, Dicker AP. Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry. Int J Radiat Oncol Biol Phys. 2001; 51: 11961199.
  • 20
    Merrick GS, Butler WM, Wallner KE, Burden LR, Dougherty JE. Extracapsular dose distribution following permanent prostate brachytherapy. Am J Clin Oncol. 2003; 26: 178189.
  • 21
    Critz F. Summary of simultaneous irradiation for prostate cancer. Urology. 2004; 64: 633636.